Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent.

Area of Science:

• Immunology
• Microbiology
• Bone Biology

Background:

• Pasteurella multocida (PM) causes respiratory disease in animals.
• Toxigenic PM strains produce a toxin (PMT) that induces atrophic rhinitis in swine by enhancing osteoclastogenesis and inhibiting osteoblast function.

Purpose of the Study:

• To investigate the cellular mechanisms underlying PMT-induced osteoclastogenesis.
• To identify the specific immune cell populations involved in PMT's effects on bone cells.

Main Methods:

• Culturing murine hematopoietic progenitor cells with PMT.
• Flow cytometry analysis to identify cell populations (e.g., CD117+, CD11b+, B220+, CD19+, IgM+).
• Co-culture experiments with purified B cells and macrophages.
• Measurement of cytokine and growth factor production (IL-1β, IL-6, TNF-α, RANKL).

Main Results:

• PMT did not induce osteoclast differentiation from hematopoietic stem cells or early macrophages.
• PMT induced the generation of a specific B-cell population (B220+/CD19+ and B220+/IgM+) within the CD117- fraction.
• These PMT-stimulated B cells were essential for efficient osteoclast generation from macrophages.
• PMT-stimulated B cells produced significantly higher levels of osteoclastogenic factors (IL-1β, IL-6, TNF-α, RANKL) compared to control B cells.

Conclusions:

• PMT-induced osteoclastogenesis is mediated by a B-cell population, not directly by hematopoietic stem cells or macrophages.
• B cells play a critical role in facilitating osteoclast formation in response to PMT.
• PMT-stimulated B cells secrete key osteoclastogenic factors, suggesting a cross-talk between lymphoid and bone cells.
• B cells represent a potential target for Pasteurella multocida infections impacting bone health.